Black Hawk Acquisition Corp
BKHA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0002000775
No open-market purchases or sales by Black Hawk Acquisition Corp insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $23.3M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Black Hawk Acquisition Corp changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 24 | 32 | +8 |
| Shares | 5.04M | 6.05M | +1.01M (+20.0%) |
| Value | $51.1M | $61.9M | +$10.8M (+21.2%) |
New holders (8)
Institutions that held Black Hawk Acquisition Corp at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Berkley W R Corp | 438,055 | $4.49M | 0.32% |
| Walleye Capital LLC | 128,000 | $1.31M | 0.01% |
| Walleye Trading LLC | 72,000 | $736.6K | 0.02% |
| Bank of Montreal | 34,648 | $355.8K | 0.00% |
| Goldman Sachs Group Inc | 29,800 | $305.2K | 0.00% |
| Calamos Advisors LLC | 24,591 | $251.6K | 0.00% |
| ADAR1 Capital Management, LLC | 15,000 | $153.6K | 0.03% |
| UBS Group AG | 10 | $102 | 0.00% |
Sold out (0)
Institutions that held Black Hawk Acquisition Corp at the end of Q2 2024 and filed for Q3 2024 without it.
None.